Promising Biomarker for HPV-Related Oropharyngeal Cancer
More than one-third of patients with oropharyngeal cancer were seropositive for HPV16 E6 an average of 6 years prior to their cancer diagnosis compared with less than 1% of healthy controls, a new study has found. (Source: Cancer Network)
Source: Cancer Network - July 23, 2013 Category: Cancer & Oncology Source Type: news
The F-Word
Fat. It isn’t said in polite company, and doctors never use it with patients because it is considered rude and inflammatory. But fat is now a disease. OK—obesity is a disease. The American Medical Association has proclaimed it as such, and now we are free to discuss it unhindered by rules of etiquette. (Source: Cancer Network)
Source: Cancer Network - July 23, 2013 Category: Cancer & Oncology Source Type: news
Dramatic Effects of Quit Smart Tobacco Cessation Program Seen in Newly Diagnosed Cancer Patients
At ONS Congress 2013, Bruce Grant explains how integrating a nurse-driven tobacco cessation program for newly diagnosed oncology patients, called Quit Smart, into regularly scheduled appointments boosted the long-term quit rate (abstract 136806). (Source: Cancer Network)
Source: Cancer Network - July 22, 2013 Category: Cancer & Oncology Source Type: news
Irregular Vaginal Bleeding in 43-Year-Old Patient
A 43-year-old woman presents with irregular vaginal bleeding. An endometrial mass is identified. (Source: Cancer Network)
Source: Cancer Network - July 22, 2013 Category: Cancer & Oncology Source Type: news
GAUGUIN: Higher Obinutuzumab Dose Shows Promise in Non-Hodgkin Lymphoma
The phase II portion of the GAUGUIN study found promising activity with the anti-CD20 antibody obinutuzumab in patients with relapsed or refractory indolent NHL. (Source: Cancer Network)
Source: Cancer Network - July 22, 2013 Category: Cancer & Oncology Source Type: news
Novel Agents Increased Risk for Engraftment Syndrome in Older Myeloma Patients
Older multiple myeloma patients exposed to novel agents prior to autologous peripheral blood stem cell transplantation were at increased risk for engraftment syndrome. (Source: Cancer Network)
Source: Cancer Network - July 22, 2013 Category: Cancer & Oncology Source Type: news
Study Links Omega-3 Fatty Acids and Prostate Cancer Risk
A large and prospective study shows that a high concentration of omega-3 fatty acids is linked to a higher risk of aggressive prostate cancer. (Source: Cancer Network)
Source: Cancer Network - July 21, 2013 Category: Cancer & Oncology Source Type: news
Combined Immunotherapies Show Promise in Metastatic Melanoma
The results of two studies indicate that combining antibodies against the programmed death 1 (PD-1) receptor with an antibody against cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) improved treatment outcomes for patients with advanced melanoma, without a significant increase in adverse events. (Source: Cancer Network)
Source: Cancer Network - July 17, 2013 Category: Cancer & Oncology Source Type: news
Death With Dignity Program Well Accepted at Seattle Cancer Center
Patients who received a prescription for a lethal dose of secobarbital as part of a Death with Dignity program qualitatively described being grateful for the prescription, whether or not it was used, according to a recent study. (Source: Cancer Network)
Source: Cancer Network - July 16, 2013 Category: Cancer & Oncology Source Type: news
Gender Inequalities Exist in Diagnosis of Bladder, Renal Cancers
General practitioners took longer to suspect a diagnosis of bladder or renal cancer in women compared with men, according to a recent study. (Source: Cancer Network)
Source: Cancer Network - July 16, 2013 Category: Cancer & Oncology Source Type: news
Remembering Old Lessons in Prostate Cancer: Avoiding Errors 'in PARPituity'
The “experts” should maintain a stringent standard regarding what merits further development and reconsider carefully and critically the available data before committing to PARP inhibition, attacks on the PI3K pathway, and vasoactive agents in prostate cancer! (Source: Cancer Network)
Source: Cancer Network - July 15, 2013 Category: Cancer & Oncology Source Type: news
'Economies of Scale' Yield Multiple Benefits for a Private, Physician-Run Oncology Practice
The community oncology practice is the nation’s headquarters in the war on cancer. Eighty-five percent of all cancer patients receive their treatment in local community oncology practices. (Source: Cancer Network)
Source: Cancer Network - July 15, 2013 Category: Cancer & Oncology Source Type: news
Targeted Therapy in the Treatment of Castration-Resistant Prostate Cancer
In this review, we focus on the testosterone/androgen receptor pathway that is being targeted with potent new agents; we also discuss other important alternative biologic pathways that have given rise to new therapeutics that may attenuate prostate cancer growth, survival, and propagation. (Source: Cancer Network)
Source: Cancer Network - July 15, 2013 Category: Cancer & Oncology Source Type: news
Extended Surgery for Retroperitoneal Sarcoma: Too Much Surgery for Some and Not Enough for Others?
Recently controversy has emerged regarding the extent of resection that constitutes optimal surgical management of retroperitoneal soft tissue sarcoma. (Source: Cancer Network)
Source: Cancer Network - July 15, 2013 Category: Cancer & Oncology Source Type: news
Extended Surgery for Retroperitoneal Sarcoma: The Key to Maximizing the Potential for Cure and Survival
Surgery is the mainstay of treatment for localized soft-tissue sarcoma (STS). It consists primarily of resection of the tumor along with a cuff of surrounding healthy tissue. (Source: Cancer Network)
Source: Cancer Network - July 15, 2013 Category: Cancer & Oncology Source Type: news
